APHLX
Price
$14.26
Change
+$0.13 (+0.92%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

APHLX vs RMFCX

Header iconAPHLX vs RMFCX Comparison
Open Charts APHLX vs RMFCXBanner chart's image
Artisan Value Institutional
Price$14.26
Change+$0.13 (+0.92%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
APHLX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APHLX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APHLX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. APHLX (348M). RMFCX pays higher dividends than APHLX: RMFCX (1.69) vs APHLX (1.01). APHLX was incepted earlier than RMFCX: APHLX (13 years) vs RMFCX (23 years). APHLX is a more actively managed with annual turnover of: 38.07 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than APHLX: RMFCX (250) vs APHLX (1000000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. APHLX (6.51). RMFCX return over 5 years is better than : 37.80 vs. APHLX (11.86).
APHLXRMFCXAPHLX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD5.8079.92159%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets348M102B0%
Annual Yield % from dividends1.011.6960%
Returns for 1 year6.5111.1159%
Returns for 3 years0.5012.384%
Returns for 5 years11.8637.8031%
Returns for 10 years18.4459.3631%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA